Abstract:Background The high mortality rate of patients with acute myocardial infarction (AMI) remains the most pressing issue of modern cardiology. Over the past 10 years, there has been no significant reduction in mortality among patients with AMI. It is quite obvious that there is an urgent need to develop fundamentally new drugs for the treatment of AMI. Angiotensin 1–7 has some promise in this regard. Objective The objective of this article is analysis of published data on the cardioprotective properties of angiotensin 1–7. Methods PubMed, Scopus, Science Direct, and Google Scholar were used to search articles for this study. Results Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart. Angiotensin 1–7 can prevent not only ischemic but also reperfusion cardiac injury. The activation of the Mas receptor plays a key role in these effects of angiotensin 1–7. Angiotensin 1–7 alleviates Ca2+ overload of cardiomyocytes and reactive oxygen species production in ischemia/reperfusion (I/R) of the myocardium. It is possible that both effects are involved in angiotensin 1–7‐triggered cardiac tolerance to I/R. Furthermore, angiotensin 1–7 inhibits apoptosis of cardiomyocytes and stimulates autophagy of cells. There is also indirect evidence suggesting that angiotensin 1–7 inhibits ferroptosis in cardiomyocytes. Moreover, angiotensin 1–7 possesses anti‐inflammatory properties, possibly achieved through NF‐kB activity inhibition. Phosphoinositide 3‐kinase, Akt, and NO synthase are involved in the infarct‐reducing effect of angiotensin 1–7. However, the specific end‐effector of the cardioprotective impact of angiotensin 1–7 remains unknown. Conclusion The molecular nature of the end‐effector of the infarct‐limiting effect of angiotensin 1–7 has not been elucidated. Perhaps, this end‐effector is the sarcolemmal KATP channel or the mitochondrial KATP channel.

Review of Recent Research on Cardiovascular Protective Effects of Angiotensin(1-7)

The Emerging Role Of Angiotensinogen In Cardiovascular Diseases

Effects of Angiotensin-( 1-7 ) in the Pathogenesis of Atherosclerosis

Review of angiotensin I converting enzyme inhibitory peptides derived from different food protein

Angiotensin-(1-7): New Perspectives in Atherosclerosis Treatment.

The effect of captopril on endothelin of cardiovascular tissues in spontaneously hypertensive rats

Neuroprotective Effect of Angiotensin-(1-7) Against Focal Cerebral Ischemic-Reperfusion Injury in Rats

Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets

Angiotensin-(1-7) Attenuates Hypertension and Cardiac Hypertrophy Via Modulation of Nitric Oxide and Neurotransmitter Levels in the Paraventricular Nucleus in Salt-Sensitive Hypertensive Rats

Angiotensin (1−7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice

Angiotensin1-7 Protects Cardiomyocytes from Hypoxia/reoxygenation-Induced Oxidative Stress by Preventing ROS-associated Mitochondrial Dysfunction and Activating the Akt Signaling Pathway.

DIFFERENT EFFECTS OF ANGIOTENSIN II AND ANGIOTENSIN-(1–7) ON ENDOTHELIAL VCAM-1 EXPRESSION DURING ATHEROSCLEROSIS

Effect of Green Tea on Angiotensin Ii Level and Myocardial Microstructure in Spontaneous Hypertensive Rats

Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure

Angiotensin-(1-7) in kidney disease: a review of the controversies

Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective

Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats.

Novel Insights into the Cardioprotective Effects of the Peptides of the Counter-Regulatory Renin–Angiotensin System

Comparative Studies of Vasodilating Effects of Angiotensin-(1-7) on the Different Vessels.

Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism

Angiotensin-(1–7) Regulates Angiotensin II-induced VCAM-1 Expression on Vascular Endothelial Cells